AqueSys (Irvine, CA) a clinical-stage medical device company focused on implants for the treatment of glaucoma, closed a $25M Series C financing. Participants include Longitude Capital, Rho Ventures, Accuitive Medical Ventures, The Carlyle Group and SV Life Sciences.